Sunzen Biotech Berhad
>
Investor Relations Home
>
Investor Information
> Analyst Reports
Board of Directors
Corporate Structure
Chairman's Statement
Corporate Presentation
AGM Webcast
Circulars & Prospectuses
Analyst Reports
Financial Statements
Quarterly Results
Stock Quotes
Charts
Annual Reports
Quarterly Reports
Email Alerts
IR Contact
Bursa Announcements
Content on this page requires a newer version of Adobe Flash Player.
Analyst Reports
23 Sept 2008
Alliance Research
Considering the weak market sentiment...we assign FY09 PER of 10.5x for Sunzen, a 20% discount to Mesdaq's trading PER of 13.1x, to derive a fair value of RM0.33.
Quick Links
Annual Report
Download PDF
Quarterly Result
Download PDF
Email Alerts
- Select One -
Institutional Investor
Retail Investor
Industry Observer
ChartNexus Sdn Bhd © 2012
Privacy Policy
|
Terms of Use
